JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:74-76; doi:10.1136/jnnp.2005.067041
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horváth, R
Right arrow Articles by Jaksch, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horváth, R
Right arrow Articles by Jaksch, M

PAPER

Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA)

R Horváth1, A Abicht2, E Holinski-Feder4, A Laner4, K Gempel1, H Prokisch5, H Lochmüller2, T Klopstock3, M Jaksch1

1 Metabolic Disease Centre Munich-Schwabing, Institutes of Clinical Chemistry, Molecular Diagnostics and Mitochondrial Genetics, Academic Hospital Schwabing, Munich, Germany
2 Friedrich-Baur-Institute and Department of Neurology, Ludwig-Maximilians University, Munich
3 Department of Neurology, Ludwig-Maximilians University
4 Medical Genetic Centre, Munich
5 GSF National Research Centre, Institute of Human Genetics, Munich

Correspondence to:
Correspondence to:
Dr Rita Horváth
Metabolic Disease Centre Munich-Schwabing, Institutes of Clinical Chemistry, Molecular Diagnostics and Mitochondrial Genetics; Academic Hospital Schwabing, Kölner Platz 1, 80804 Munich, Germany; Rita.Horvath{at}lrz.uni-muenchen.de

Detailed clinical, neuroradiological, histological, biochemical, and genetic investigations were undertaken in a child suffering from Leigh syndrome. The clinical symptoms started at age five months and led to a severe progressive neurodegenerative disorder causing epilepsy, psychomotor retardation, and tetraspasticity. Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial complex II. Sequencing of SDHA revealed compound heterozygosity for a nonsense mutation in exon 4 (W119X) and a missense mutation in exon 3 (A83V), both absent in normal controls. In six additional patients—five with Leigh or Leigh-like syndrome and one with neuropathy and ataxia associated with isolated deficiency of complex II—mutations in SDHA were not detected, indicating genetic heterogeneity.


Abbreviations: DHPLC, denaturing high performance liquid chromatography; RC, respiratory chain; SDH, succinate dehydrogenase

Keywords: Leigh syndrome; SDHA; complex II




This article has been cited by other articles:


Home page
NEJMHome page
K. J. Staley, K. B. Sims, P. E. Grant, and E. T. Hedley-Whyte
Case 28-2008 -- An 8-Day-Old Infant with Congenital Deafness, Lethargy, and Hypothermia
N. Engl. J. Med., September 11, 2008; 359(11): 1156 - 1167.
[Full Text] [PDF]


Home page
DevelopmentHome page
J. D. Mast, K. M. H. Tomalty, H. Vogel, and T. R. Clandinin
Reactive oxygen species act remotely to cause synapse loss in a Drosophila model of developmental mitochondrial encephalopathy
Development, August 1, 2008; 135(15): 2669 - 2679.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J.-J. Briere, J. Favier, A.-P. Gimenez-Roqueplo, and P. Rustin
Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation
Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1114 - C1120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.